MYRIAD GENETICS, INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
MYRIAD GENETICS, INC. (MYGN) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $12.70 million for the 12-month period ending 2016-06-30, per its 10-K filed 2017-08-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2017-08-09
- MYRIAD GENETICS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $12.70M, a 273.53% increase from fiscal 2015.
- MYRIAD GENETICS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $3.40M, a 69.37% decline from fiscal 2014.
- MYRIAD GENETICS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $11.10M, a 40.51% increase from fiscal 2013.
- MYRIAD GENETICS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $7.90M, a 76.90% decline from fiscal 2012.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month as first filed |
|---|---|---|
| 2016-06-30 | $12.70M 10-K · filed 2017-08-09 | |
| 2015-06-30 | $3.40M 10-K · filed 2017-08-09 | |
| 2014-06-30 | $11.10M 10-K · filed 2016-08-10 | $11.14M 10-K · filed 2014-08-13 |
| 2013-06-30 | $7.90M 10-K · filed 2015-08-12 | $7.89M 10-K · filed 2013-08-14 |
| 2012-06-30 | $34.19M 10-K · filed 2014-08-13 | |
| 2011-06-30 | $58.83M 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |